Skip to main content

abbv-2001

abbv-2001: 1 clinical trial tracked.

abbv-2001 evidence translation

What we can confirm

1 tracked trial

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about abbv-2001, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors

Related indications

Clinical Trial Registry Records (1)

A Phase 1/2, Open-Label, Platform Study to Evaluate Safety and Efficacy of T Cell Engaging Bi/Tri-specific Antibodies in Subjects With MM

NCT06892522Registry updated 2026-07-21·Phase 1/Phase 2·ABBV
Recruiting

Primary endpoint: Number of Participants with Adverse Events (AE)s

InterventionalRandomizedopen602 targetStarted 2025-06Completion 2035-1234 sites · Australia, Israel, Japan, Norway…AbbVie